''In other developments, a research team from the University of Hong Kong today published a modeling study that suggests early use of a secondary antiviral medication at the local level during a pandemic might delay resistance to the primary drug. The findings appear in an early online edition of Public Library of Science Medicine (PLoS Medicine).
In the current swine influenza outbreak setting, the authors said the secondary drug would be zanamivir (Relenza), the only other drug besides oseltamivir (Tamiflu) that has shown to be effective against the new virus''